The pathophysiological mechanisms involved in the development of PTDM include increased insulin resistance, altered insulin production due to damage to pancreatic beta cells (due to inflammatory factors, oxidative stress, mitochondrial dysfunction, etc.), and uncontrolled release of glucagon [26]. This evidence concerns the gene INS and Insulin resistance.